Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 64151-64200 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06029257
A Study of Tildrakizumab in the Treatment of Genital Psoriasis (CZATCH-Genital-PsO)
N/ARecruiting
110 participants
Started: Nov 14, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT06154291
FIH XON7 in Advanced/Metastatic Solid Tumors
PHASE1/PHASE2Recruiting
255 participants
Started: Nov 14, 2023 · Completed: Nov 30, 2027
2 conditions1 sponsor5 locations
NCT06231732
The Hi-tACS on Cognitive Function in Patients With Schizophrenia: a Pilot Study
NARecruiting
12 participants
Started: Nov 14, 2023 · Completed: Aug 1, 2024
1 condition2 sponsors1 location
NCT06838611
ChAracterization of Patients and Treatment OUtcomes in Severe Tricuspid Regurgitation
N/ARecruiting
300 participants
Started: Nov 14, 2023 · Completed: Jul 1, 2028
3 conditions6 sponsors1 location
NCT06128551
Study of RMC-6291 in Combination with RMC-6236 in Participants with Advanced KRAS G12C Mutant Solid Tumors
PHASE1Recruiting
210 participants
Started: Nov 14, 2023 · Completed: Nov 30, 2026
3 conditions1 sponsor54 locations
NCT06257251
Silicone Particles in Breast Implant Capsules
N/ARecruiting
65 participants
Started: Nov 14, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06235749
Administration Of Calcium Gluconate for The Reduction of Blood Loss During Elective Cesarean Delivery
NARecruiting
1,180 participants
Started: Nov 14, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor4 locations
NCT06088329
Mindful Walking for Adults With Chronic Pain
NARecruiting
15 participants
Started: Nov 14, 2023 · Completed: Dec 31, 2023
1 condition1 sponsor1 location
NCT06097364
A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma
PHASE3Active, not recruiting
733 participants
Started: Nov 14, 2023 · Completed: Jul 29, 2029
1 condition1 sponsor144 locations
NCT06369194
POWER AUDIT, Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol
N/AActive, not recruiting
847 participants
Started: Nov 14, 2023 · Completed: Apr 15, 2024
5 conditions1 sponsor36 locations
NCT06158659
Improved Immunology Outcomes Associated With Lactoferrin Fortified With HMO in Infant Formula
NARecruiting
240 participants
Started: Nov 14, 2023 · Completed: Apr 30, 2025
2 conditions1 sponsor1 location
NCT06333275
Restoration of Immunity to Vaccine Preventable Diseases After CART-T Cell Therapy
N/ARecruiting
80 participants
Started: Nov 14, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06104449
A Study of Opevesostat (MK-568)4 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005)
PHASE1Active, not recruiting
6 participants
Started: Nov 14, 2023 · Completed: Apr 12, 2026
2 conditions2 sponsors3 locations
NCT05658640
HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies
PHASE1/PHASE2Recruiting
26 participants
Started: Nov 14, 2023 · Completed: Apr 1, 2029
5 conditions4 sponsors36 locations
NCT06003231
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
PHASE2Active, not recruiting
120 participants
Started: Nov 14, 2023 · Completed: May 31, 2028
4 conditions1 sponsor92 locations
NCT05583617
A Study Evaluating the Safety and Efficacy of Multiple Treatments in Participants With Multiple Myeloma
PHASE1/PHASE2Recruiting
200 participants
Started: Nov 14, 2023 · Completed: Jul 31, 2028
1 condition1 sponsor16 locations
NCT06159673
ACP-204 in Adults With Alzheimer's Disease Psychosis
PHASE2/PHASE3Recruiting
1,074 participants
Started: Nov 14, 2023 · Completed: Feb 29, 2028
1 condition1 sponsor133 locations
NCT06546345
Post Market Clinical Follow-Up KeriFlex®
N/ARecruiting
86 participants
Started: Nov 14, 2023 · Completed: Jan 31, 2035
3 conditions1 sponsor3 locations
NCT06075316
Improving Thoracic Surgical Care Using Electronic Patient-Reported Outcomes (ePROS)
NARecruiting
200 participants
Started: Nov 14, 2023 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05708534
Evolution of CMV Antiviral T-cell Immunity Over the Next Six Months Initiation of Treatment With Belatacept.
N/ARecruiting
28 participants
Started: Nov 14, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06064149
The CArdiovascular Risk Evaluation in Men With Prostate Cancer Study (CARE-PC) Pilot Feasibility Study
NARecruiting
100 participants
Started: Nov 14, 2023 · Completed: Aug 1, 2026
1 condition2 sponsors1 location
NCT06116968
An Open-Label Study of Aficamten for Chinese Patients With Symptomatic oHCM
PHASE3Recruiting
44 participants
Started: Nov 14, 2023 · Completed: Mar 15, 2026
1 condition1 sponsor12 locations
NCT06102876
Feasibility of Physical Activity in Older Adults With Haematological Malignancies: ACCES Study
N/AActive, not recruiting
69 participants
Started: Nov 14, 2023 · Completed: Sep 30, 2025
2 conditions1 sponsor1 location
NCT06159088
Improved Gut Health Outcomes Associated With Probiotics Fortified With Hydrolyzed Whey Protein in Infant Formula
NARecruiting
240 participants
Started: Nov 14, 2023 · Completed: Apr 30, 2025
2 conditions1 sponsor1 location
NCT06005194
InMotion - Telehealth Delivered Exercise Promotion to Treat Major Depression After TBI
NARecruiting
80 participants
Started: Nov 14, 2023 · Completed: Sep 30, 2027
5 conditions2 sponsors1 location
NCT06102798
Acupuncture for Lumbar Spinal Stenosis
NARecruiting
420 participants
Started: Nov 14, 2023 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05953428
Reducing Postoperative Opioids in Patients Undergoing Laparoscopic Hiatal Hernia
NARecruiting
75 participants
Started: Nov 14, 2023 · Completed: Feb 1, 2026
1 condition1 sponsor1 location
NCT05835479
Rezafungin for Treatment of Pneumocystis Pneumonia in HIV Adults
PHASE2Recruiting
50 participants
Started: Nov 14, 2023 · Completed: Aug 31, 2025
1 condition1 sponsor6 locations
NCT05708547
Role of Mitophagy in Myeloid Cells During Coronary Atherosclerosis.
N/ARecruiting
50 participants
Started: Nov 14, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06945315
SAFE Nerve Sparing Guided by Micro-ultrasound (MUS)
PHASE3Recruiting
196 participants
Started: Nov 14, 2023 · Completed: Jul 14, 2027
2 conditions1 sponsor1 location
NCT05477537
Adapted Physical Activity in the Treatment of Anorexia:
NARecruiting
220 participants
Started: Nov 14, 2023 · Completed: Apr 30, 2027
1 condition1 sponsor7 locations
NCT06019767
Peer-led Trauma Therapy for Re-entry
NAActive, not recruiting
72 participants
Started: Nov 14, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05668390
Safety and Efficacy of STALORAL® Birch 300 IR in a Paediatric Population With Birch Pollen-induced ARC w/o Asthma
PHASE3Active, not recruiting
699 participants
Started: Nov 14, 2023 · Completed: Nov 30, 2025
2 conditions1 sponsor62 locations
NCT05934669
IN Midazolam vs IN Dexmedetomidine vs IN Ketamine During Minimal Procedures in Pediatric ED
PHASE4Recruiting
90 participants
Started: Nov 14, 2023 · Completed: Jun 30, 2025
3 conditions1 sponsor1 location
NCT06993727
Autoimmune Endocrine Disease Related Antibodies Before the Start of Immune Checkpoint Inhibitor Therapy
NARecruiting
500 participants
Started: Nov 14, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor3 locations
NCT06062420
A Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck- GALAXIES H&N-202
PHASE2Active, not recruiting
316 participants
Started: Nov 14, 2023 · Completed: Jul 27, 2027
1 condition2 sponsors113 locations
NCT06146387
Improved Cognitive Outcomes Associated With Feihe HMO With DHA/ARA in Infant Formula
NARecruiting
240 participants
Started: Nov 14, 2023 · Completed: Apr 30, 2025
1 condition1 sponsor1 location
NCT06098521
Project CONSENT: Cognitive Behavioral Therapy to Prevent Sexual Recidivism
NARecruiting
228 participants
Started: Nov 14, 2023 · Completed: Feb 27, 2026
1 condition2 sponsors2 locations
NCT06158698
CMP-MYTHiC Trial and Registry - CardioMyoPathy With MYocarditis THerapy With Colchicine
PHASE3Recruiting
80 participants
Started: Nov 14, 2023 · Completed: May 2, 2028
5 conditions5 sponsors10 locations
NCT06183086
PMCF Study on the Safety of Linovera® for the Treatment of Category-I Pressure Ulcers/Injuries
N/ARecruiting
95 participants
Started: Nov 14, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT04632628
Web-based Cognitive Behavioral Treatment for Insomnia in Dementia Caregivers
NARecruiting
60 participants
Started: Nov 14, 2023 · Completed: Mar 31, 2027
2 conditions1 sponsor1 location
NCT05983133
A Study of PF-08046052/SGN-EGFRd2 in Advanced Solid Tumors
PHASE1Recruiting
290 participants
Started: Nov 14, 2023 · Completed: Jan 9, 2030
4 conditions1 sponsor24 locations
NCT05995171
Long Term Outcome of Easophageal Atresia : Transmics Profiles in Adolescence
N/ARecruiting
300 participants
Started: Nov 14, 2023 · Completed: Nov 14, 2026
1 condition2 sponsors33 locations
NCT05923008
A Clinical Study of IBI130 for Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors
PHASE1/PHASE2Recruiting
182 participants
Started: Nov 14, 2023 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT06356116
Rehabilitation After Direct Anterior Approach for Total Hip Arthroplasty
NARecruiting
60 participants
Started: Nov 14, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06141915
Aerobic Training and Diet Protocol on Immune System in Burn Patients.
NARecruiting
90 participants
Started: Nov 14, 2023 · Completed: May 19, 2024
1 condition1 sponsor1 location
NCT05978414
Functional Links Between the Temporomandibular Joint and the Pelvis in Gynecology
NARecruiting
200 participants
Started: Nov 14, 2023 · Completed: Sep 1, 2026
2 conditions2 sponsors1 location
NCT06112379
A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer
PHASE3Active, not recruiting
1,902 participants
Started: Nov 14, 2023 · Completed: Sep 23, 2032
1 condition2 sponsors283 locations
NCT06138964
Comparing the Effect of siSPARC Microneedle Patch Versus siSPARC+siLR4A Microneedle Patch on Post-surgical Scars
PHASE2Recruiting
50 participants
Started: Nov 14, 2023 · Completed: Nov 14, 2024
3 conditions1 sponsor1 location
NCT06119867
CompariSon Between the EuroPeAn and Japanese pathologiCal InvEstigation for Colon Cancer (SPACE)
PHASE3Recruiting
430 participants
Started: Nov 14, 2023 · Completed: Dec 1, 2025
1 condition1 sponsor1 location